1-11 of 11
Don J. Diamond
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 5261: Immunologic signatures of peripheral blood cells in patients with advanced pancreatic cancer under lenvatinib-pembrolizumab maintenance therapy

Vincent Chung, Ferdynand Kos, Edwin Manual, Shannon Dempsey, Don J. Diamond
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 5261.
https://doi.org/10.1158/1538-7445.AM2024-5261
Published: 22 March 2024
View article titled, Abstract 5261: Immunologic signatures of peripheral blood cells in patients with advanced pancreatic cancer under lenvatinib-pembrolizumab maintenance therapy
Journal Articles

Abstract A97: Control of PDAC tumor progression by RNA interference targeting indoleamine 2,3-dioxygenase using salmonella as a delivery vehicle facilitated by PEGPH20

Edwin R. Manuel, Melanie G. Lampa, Joseph Kim, Vincent Chung, Massimo D'Apuzzo, Curtis B. Thompson, Zhongdong Huang, Daniel C. Maneval, Don J. Diamond
Journal: Cancer Research
Cancer Res (2015) 75 (13_Supplement): A97.
https://doi.org/10.1158/1538-7445.PANCA2014-A97
Published: 30 June 2015
View article titled, Abstract A97: Control of PDAC tumor progression by RNA interference targeting indoleamine 2,3-dioxygenase using salmonella as a delivery vehicle facilitated by PEGPH20
Journal Articles

Effective Cancer Vaccine Platform Based on Attenuated Salmonella and a Type III Secretion System

Xin Xu, Wael A.H. Hegazy, Linjie Guo, Xiuhua Gao, Amy N. Courtney, Suhrab Kurbanov, Daofeng Liu, Gengwen Tian, Edwin R. Manuel, Don J. Diamond, Michael Hensel, Leonid S. Metelitsa
Journal: Cancer Research
Cancer Res (2014) 74 (21): 6260–6270.
https://doi.org/10.1158/0008-5472.CAN-14-1169
Published: 30 October 2014
View article titled, Effective Cancer Vaccine Platform Based on Attenuated <em>Salmonella</em> and a Type III Secretion System
Open the PDF for Effective Cancer Vaccine Platform Based on Attenuated <em>Salmonella</em> and a Type III Secretion System in another window
Includes: Supplementary data
Journal Articles

TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy

Chan Gao, Anna Kozlowska, Sergey Nechaev, Haiqing Li, Qifang Zhang, Dewan M.S. Hossain, Claudia M. Kowolik, Peiguo Chu, Piotr Swiderski, Don J. Diamond, Sumanta K. Pal, Andrew Raubitschek, Marcin Kortylewski
Journal: Cancer Research
Cancer Res (2013) 73 (24): 7211–7221.
https://doi.org/10.1158/0008-5472.CAN-13-1314
Published: 16 December 2013
View article titled, TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy
Open the PDF for TLR9 Signaling in the Tumor Microenvironment Initiates Cancer Recurrence after Radiotherapy in another window
Journal Articles

Tumor Growth Control with IDO-Silencing Salmonella—Reply

Edwin R. Manuel, Bruce R. Blazar, Don J. Diamond
Journal: Cancer Research
Cancer Res (2013) 73 (14): 4592–4593.
https://doi.org/10.1158/0008-5472.CAN-13-1274
Published: 15 July 2013
View article titled, Tumor Growth Control with IDO-Silencing <em>Salmonella</em>—Reply
Open the PDF for Tumor Growth Control with IDO-Silencing <em>Salmonella</em>—Reply in another window
Journal Articles

Systemic Delivery of Salmonella typhimurium Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth

Céline A. Blache, Edwin R. Manuel, Teodora I. Kaltcheva, Andrea N. Wong, Joshua D.I. Ellenhorn, Bruce R. Blazar, Don J. Diamond
Journal: Cancer Research
Cancer Res (2012) 72 (24): 6447–6456.
https://doi.org/10.1158/0008-5472.CAN-12-0193
Published: 16 December 2012
View article titled, Systemic Delivery of <em>Salmonella typhimurium</em> Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth
Open the PDF for Systemic Delivery of <em>Salmonella typhimurium</em> Transformed with IDO shRNA Enhances Intratumoral Vector Colonization and Suppresses Tumor Growth in another window
Includes: Supplementary data
Journal Articles

Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-Targeting Salmonella-Based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors

Edwin R. Manuel, Céline A. Blache, Rebecca Paquette, Teodora I. Kaltcheva, Hidenobu Ishizaki, Joshua D.I. Ellenhorn, Michael Hensel, Leonid Metelitsa, Don J. Diamond
Journal: Cancer Research
Cancer Res (2011) 71 (12): 4183–4191.
https://doi.org/10.1158/0008-5472.CAN-10-4676
Published: 14 June 2011
View article titled, Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-Targeting <em>Salmonella-</em>Based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors
Open the PDF for Enhancement of Cancer Vaccine Therapy by Systemic Delivery of a Tumor-Targeting <em>Salmonella-</em>Based STAT3 shRNA Suppresses the Growth of Established Melanoma Tumors in another window
Includes: Supplementary data
Journal Articles

Abstract 2420: Modified vaccinia Ankara (MVA) expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model

Hidenobu Ishizaki, Edwin Manuel, Tumul Srivastava, Guang-Yun Song, Don J. Diamond, Joshua D.I. Ellenhorn
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2420.
https://doi.org/10.1158/1538-7445.AM10-2420
Published: 15 April 2010
View article titled, Abstract 2420: Modified vaccinia Ankara (MVA) expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model
Journal Articles

Two Distinct Pathways of Immuno-Modulation Improve Potency of p53 Immunization in Rejecting Established Tumors

Pirouz Daftarian, Guang-Yun Song, Saima Ali, Moshe Faynsod, Jeff Longmate, Don J. Diamond, Joshua D. I. Ellenhorn
Journal: Cancer Research
Cancer Res (2004) 64 (15): 5407–5414.
https://doi.org/10.1158/0008-5472.CAN-04-0169
Published: 02 August 2004
View article titled, Two Distinct Pathways of Immuno-Modulation Improve Potency of p53 Immunization in Rejecting Established Tumors
Open the PDF for Two Distinct Pathways of Immuno-Modulation Improve Potency of p53 Immunization in Rejecting Established Tumors in another window
Journal Articles

Targeting of Human p53-overexpressing Tumor Cells by an HLA A*0201-restricted Murine T-Cell Receptor Expressed in Jurkat T Cells

Xiping Liu, Elizabeth A. Peralta, Joshua D. I. Ellenhorn, Don J. Diamond
Journal: Cancer Research
Cancer Res (2000) 60 (3): 693–701.
Published: 01 February 2000
View article titled, Targeting of Human p53-overexpressing Tumor Cells by an HLA A*0201-restricted Murine T-Cell Receptor Expressed in Jurkat T Cells
Open the PDF for Targeting of Human p53-overexpressing Tumor Cells by an HLA A*0201-restricted Murine T-Cell Receptor Expressed in Jurkat T Cells in another window
Journal Articles

Targeting p53 for Adoptive T-Cell Immunotherapy

Todd M. McCarty, Xiping Liu, Ji-Yao Sun, Elizabeth A. Peralta, Don J. Diamond, Joshua D. I. Ellenhorn
Journal: Cancer Research
Cancer Res (1998) 58 (12): 2601–2605.
Published: 01 June 1998
View article titled, Targeting p53 for Adoptive T-Cell Immunotherapy
Open the PDF for Targeting p53 for Adoptive T-Cell Immunotherapy in another window